5AM Venture Management, LLC
Portfolio
Holdings
Symbol | Name | Country | Sector | Industry | Most recent quarter | % of Total Shares | % of Total Assets | Shares | Book Value | Market Price Value | Fundamental Score | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ADVM.NASDAQ | Adverum Biotechnologies Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 2.604 | 0.786 | 541.6k | $3.7m | $2.5m |
| |||||||||||||
AKUS.NASDAQ | AKUS.NASDAQ | - | - | - | - | 11.19 | 5.356 | 4.1m | - | - | ||||||||||||||
ANAB.NASDAQ | AnaptysBio Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.176 | 2.476 | 357.7k | $991.9k | $4.9m |
| |||||||||||||
CABA.NASDAQ | Cabaletta Bio Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 7.115 | 0.541 | 2m | $7.2m | $4.8m |
| |||||||||||||
CDTX.NASDAQ | Cidara Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.519 | 0.126 | 56.7k | $599.6k | $1.3m |
| |||||||||||||
CINC.NASDAQ | CINC.NASDAQ | - | - | - | - | 11.28 | 16.31 | 4.9m | - | - | ||||||||||||||
CNTA.NASDAQ | Centessa Pharmaceuticals PLC ADR | USA | Healthcare | Biotechnology | 2024-09-30 | 0.968 | 2.515 | 1.2m | $4.7m | $21m |
| |||||||||||||
COGT.NASDAQ | Cogent Biosciences Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.616 | 2.52 | 1.1m | $3.2m | $8.8m |
| |||||||||||||
CRNX.NASDAQ | Crinetics Pharmaceuticals Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.577 | 3.871 | 862.2k | $7.7m | $46.5m |
| |||||||||||||
ERAS.NASDAQ | Erasca Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.912 | 3.049 | 5.4m | $8.6m | $13.8m |
| |||||||||||||
EYPT.NASDAQ | Eyepoint Pharmaceuticals Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.538 | 1.733 | 1m | $3.3m | $7.6m |
| |||||||||||||
FIXX.NASDAQ | FIXX.NASDAQ | - | - | - | - | 7.803 | 0.732 | 4.5m | - | - | ||||||||||||||
FVAM.NASDAQ | FVAM.NASDAQ | - | - | - | - | 3.426 | 0.7 | 365.1k | - | - | ||||||||||||||
GHRS.NASDAQ | GH Research PLC | USA | Healthcare | Biotechnology | 2024-09-30 | 1.101 | 0.792 | 572.6k | $2m | $4m |
| |||||||||||||
GMTX.NASDAQ | GMTX.NASDAQ | - | - | - | - | 3.381 | 3.145 | 588.4k | - | - | ||||||||||||||
IDYA.NASDAQ | Ideaya Biosciences Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.512 | 3.05 | 868.5k | $11.8m | $21.9m |
| |||||||||||||
IMPL.NASDAQ | IMPL.NASDAQ | - | - | - | - | 12.07 | 0.357 | 2.8m | - | - | ||||||||||||||
JANX.NASDAQ | Janux Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.067 | 1.579 | 446.2k | $5.3m | $25m |
| |||||||||||||
MRSN.NASDAQ | Mersana Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.056 | 0.51 | 1.3m | $10.4k | $2.1m |
| |||||||||||||
PEAR.NASDAQ | PEAR.NASDAQ | - | - | - | - | 11.73 | 1.092 | 16.7m | - | - | ||||||||||||||
PRAX.NASDAQ | Praxis Precision Medicines Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.824 | 4.042 | 340k | $6.8m | $26.2m |
| |||||||||||||
RLYB.NASDAQ | Rallybio Corp | USA | Healthcare | Biotechnology | 2024-09-30 | 8.751 | 0.878 | 3.6m | $5.7m | $3.1m |
| |||||||||||||
SCPH.NASDAQ | Scpharmaceuticals Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 2.399 | 1.131 | 1.2m | $737.1k | $4m |
| |||||||||||||
SLN.NASDAQ | Silence Therapeutics PLC | USA | Healthcare | Biotechnology | 2024-09-30 | 1.009 | 1.789 | 476.2k | $1.1m | $3.3m |
| |||||||||||||
SPRB.NASDAQ | Spruce Biosciences Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 5.807 | 1.837 | 2.3m | $2.9m | $936.1k |
| |||||||||||||
TRDA.NASDAQ | Entrada Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 11.78 | 14.56 | 4.4m | $45.8m | $77.4m |
| |||||||||||||
TYRA.NASDAQ | Tyra Biosciences Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.856 | 4.563 | 939.2k | $5.7m | $13.2m |
| |||||||||||||
VOR.NASDAQ | Vor Biopharma Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 9.264 | 0.92 | 6.3m | $6.7m | $5.5m |
| |||||||||||||
ZNTL.NASDAQ | Zentalis Pharmaceuticals Llc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.692 | 1.969 | 490k | $2.4m | $1.5m |
|
Trades
Buys
Report date: 2024-06-30
Trade | Current | |||||
---|---|---|---|---|---|---|
Symbol | Shares | % | Total | $ Range | Price | % |
CDTX.NASDAQ | 56.7k | - | 526.9k | 1-15 | $23.43 | 4,584.1% |
ERAS.NASDAQ | 5.4m | - | 11.6m | 2-3 | $2.57 | 47.7% |
Report date: 2024-03-31
Trade | Current | |||||
---|---|---|---|---|---|---|
Symbol | Shares | % | Total | $ Range | Price | % |
ADVM.NASDAQ | 541.6k | - | 1.5m | 1-18 | $4.74 | 529.4% |
CNTA.NASDAQ | 1.2m | - | 11.7m | 7-12 | $16.90 | 154.1% |
PRAX.NASDAQ | 340k | - | 15.2m | 21-67 | $77.25 | 276.8% |
SLN.NASDAQ | 476.2k | - | 10.3m | 16-28 | $7.00 | -56.3% |
Report date: 2023-09-30
Trade | Current | |||||
---|---|---|---|---|---|---|
Symbol | Shares | % | Total | $ Range | Price | % |
TYRA.NASDAQ | 411.4k | - | 6.1m | 13-17 | $14.09 | 7.4% |
Report date: 2023-03-31
Trade | Current | |||||
---|---|---|---|---|---|---|
Symbol | Shares | % | Total | $ Range | Price | % |
SPRB.NASDAQ | 2.3m | - | 5.8m | 1-4 | $0.40 | -63.3% |
Report date: 2022-12-31
Trade | Current | |||||
---|---|---|---|---|---|---|
Symbol | Shares | % | Total | $ Range | Price | % |
ANAB.NASDAQ | 357.7k | - | 10.1m | 25-32 | $13.89 | -44.7% |
Report date: 2022-09-30
Trade | Current | |||||
---|---|---|---|---|---|---|
Symbol | Shares | % | Total | Price Range | Price | % |
GMTX.NASDAQ | 524.5k | - | 826.1k | 1-2 | - | - |
Sells
Report date: 2023-12-31
Trade | Current | |||||
---|---|---|---|---|---|---|
Symbol | Shares | % | Total | Price Range | Price | % |
IMPL.NASDAQ | -2.8m | -100.0 | -0.00 | 0-0 | - | - |
Adds
Report date: 2024-09-30
Trade | Current | |||||
---|---|---|---|---|---|---|
Symbol | Shares | % | Total | $ Range | Price | % |
EYPT.NASDAQ | 1m | 2,000.0 | 8.7m | 7-11 | $7.33 | -0.9% |
Report date: 2024-03-31
Trade | Current | |||||
---|---|---|---|---|---|---|
Symbol | Shares | % | Total | $ Range | Price | % |
GHRS.NASDAQ | 168.2k | 41.6 | 1.3m | 5-12 | $7.09 | 38.5% |
TYRA.NASDAQ | 384.3k | 69.2 | 6.3m | 11-21 | $14.09 | 25.4% |
Report date: 2023-12-31
Trade | Current | |||||
---|---|---|---|---|---|---|
Symbol | Shares | % | Total | $ Range | Price | % |
TYRA.NASDAQ | 143.5k | 34.9 | 1.8m | 10-16 | $14.09 | 35.7% |
Report date: 2023-06-30
Trade | Current | |||||
---|---|---|---|---|---|---|
Symbol | Shares | % | Total | $ Range | Price | % |
MRSN.NASDAQ | 120k | 10.1 | 695.4k | 3-10 | $1.62 | -45.5% |
Report date: 2022-12-31
Trade | Current | |||||
---|---|---|---|---|---|---|
Symbol | Shares | % | Total | Price Range | Price | % |
GMTX.NASDAQ | 535.9k | 1,021.9 | 0.00 | 0-0 | - | - |
Report date: 2022-09-30
Trade | Current | |||||
---|---|---|---|---|---|---|
Symbol | Shares | % | Total | Price Range | Price | % |
CINC.NASDAQ | 600k | 13.8 | 16.8m | 16-43 | - | - |
Report date: 2022-06-30
Trade | Current | |||||
---|---|---|---|---|---|---|
Symbol | Shares | % | Total | $ Range | Price | % |
COGT.NASDAQ | 417.7k | 58.7 | 2.8m | 4-11 | $7.86 | 107.4% |
Reduces
Report date: 2023-03-31
Trade | Current | |||||
---|---|---|---|---|---|---|
Symbol | Shares | % | Total | $ Range | Price | % |
IDYA.NASDAQ | -327.7k | -27.4 | -5.4m | 13-19 | $25.30 | 88.7% |
RLYB.NASDAQ | -100k | -2.7 | -645.8k | 4-10 | $0.86 | -79.3% |
SCPH.NASDAQ | -1.5m | -56.1 | -11.2m | 6-10 | $3.38 | -38.5% |
Report date: 2022-12-31
Trade | Current | |||||
---|---|---|---|---|---|---|
Symbol | Shares | % | Total | Price Range | Price | % |
PEAR.NASDAQ | -159.4k | -0.9 | -335.3k | 1-3 | - | - |
SCPH.NASDAQ | -600k | -18.0 | -3.6m | 4-8 | $3.38 | -8.2% |
Report date: 2022-09-30
Trade | Current | |||||
---|---|---|---|---|---|---|
Symbol | Shares | % | Total | $ Range | Price | % |
IDYA.NASDAQ | -201.7k | -14.4 | -2.6m | 9-16 | $25.30 | 181.1% |
PEAR.NASDAQ | -1.7m | -9.3 | -2.9m | 1-3 | - | - |
SCPH.NASDAQ | -226.6k | -6.4 | -1.2m | 4-7 | $3.38 | -24.2% |
Report date: 2022-06-30
Trade | Current | |||||
---|---|---|---|---|---|---|
Symbol | Shares | % | Total | $ Range | Price | % |
RLYB.NASDAQ | -250k | -6.3 | -2.3m | 6-15 | $0.86 | -85.5% |
SCPH.NASDAQ | -270k | -7.0 | -1.3m | 4-7 | $3.38 | -15.9% |
Comments
How you think about this?